Clinical Trials Browser

Phase 3 × Completed × fedratinib × Clear all

NCT03952039 2025-08-28

FREEDOM2

Phase 3 Completed

202 enrolled 23 charts

Myeloproliferative Disorders, Primary Myelofibrosis

NCT01437787 2025-03-05

JAKARTA

Phase 3 Completed

289 enrolled 1 FDA

Other hematologic neoplasm

Hematologic Neoplasms